
Saral Thangam
About Saral Thangam
Data last updated:
Saral Thangam is a Director at Alvogen Pharma (India) Private Limited (since 2014) and Managing Director at Norwich Clinical Services Private Limited (since 2010). The companies operate in Pharma, Life Sciences and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Alvogen Pharma (India) Private Limited at ₹51.32 Cr (FY 2025). Earlier, Saral Thangam was a Director at Alvotech Biosciences India Private Limited (2022–2024) and Managing Director at Lotus Labs Private Limited (2006–2010) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Sep 2014 | 2010 | ₹51.32 Cr (FY 2025) | Active | |
| Managing Director | 01 Feb 2010 | 2009 | ₹51.26 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 May 2022 | 2022 | ₹33.54 Cr (FY 2025) | Active | |
| Managing Director | 01 Nov 2006 | 1999 | ₹54.98 Cr (FY 2025) | Active | |
| Director | 19 Jan 2013 | 1990 | ₹6.2 Lakh (FY 2025) | Active | |
| Director | 19 Oct 2010 | 1986 | ₹24.7 Lakh (FY 2025) | Active | |
| Director | 27 Nov 2003 | 2003 | Strike Off | ||
| Director | 21 Nov 2006 | 2006 | Amalgamated | ||
| Director | 07 Feb 2007 | 2007 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Saral Thangam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditya Nagaraj Bellur | 07231827 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Director |
| Divya Chandu Patel | 03132296 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Nominee Director |
| Fjalar Kristjansson | 02504768 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saral Thangam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saral Thangam
Saral Thangam currently holds 2 directorships: Alvogen Pharma (India) Private Limited (Director, since 20 Sep 2014, revenue ₹51.32 Cr (FY 2025)); Norwich Clinical Services Private Limited (Managing Director, since 01 Feb 2010, revenue ₹51.26 Cr (FY 2025)).
Saral Thangam was first appointed on 27 Nov 2003 as Director at Shaman Scientific Information Systems Private Limited. The most recent appointment on record is 11 May 2022 at Alvotech Biosciences India Private Limited.
The 2 current companies of Saral Thangam that report revenue have a combined latest revenue of ₹103 Cr: Alvogen Pharma (India) Private Limited ₹51.32 Cr (FY 2025); Norwich Clinical Services Private Limited ₹51.26 Cr (FY 2025).
Saral Thangam held 7 earlier board appointments: Alvotech Biosciences India Private Limited (Director, 11 May 2022 to 24 May 2024); Lotus Labs Private Limited (Managing Director, 01 Nov 2006 to 19 Jan 2010); Jaya Chelve Chit Funds Private Limited (Director, 19 Jan 2013 to 29 Oct 2014); Jayachelve Financing And Leasing Private Limited (Director, 19 Oct 2010 to 29 Oct 2014); Shaman Scientific Information Systems Private Limited (Director, 27 Nov 2003 to 15 May 2017); and 2 more.
The current boards of Saral Thangam's companies include Aditya Nagaraj Bellur (Alvogen Pharma (India) Private Limited), Divya Chandu Patel (Alvogen Pharma (India) Private Limited), Fjalar Kristjansson (Alvogen Pharma (India) Private Limited).